Description
Seretide is indicated in the regular treatment of asthma where use of a combination product (long-acting-beta2-agonist and inhaled corticosteroid) is appropriate: Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting-beta2-agonist or Patients already adequately controlled on both inhaled corticosteroids and longacting-beta2-agonist .
